Showing results (681-690 of 1,120) with videos related to
Sort By:
Pageof 112
Journal of Thrombosis and Haemostasis : JTH|December 21, 2025
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trialNick van Es, Luuk J J Scheres, Kristen M Sanfilippo, et al.Circulation|February 8, 2021
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 UpdateDominick J Angiolillo, Deepak L Bhatt, Christopher P Cannon, et al.Plos Pathogens|June 22, 2019
The lectin-specific activity of Toxoplasma gondii microneme proteins 1 and 4 binds Toll-like receptor 2 and 4 N-glycans to regulate innate immune primingAline Sardinha-Silva, Flávia C Mendonça-Natividade, Camila F Pinzan, et al.Circulation. Cardiovascular Interventions|July 13, 2019
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary InterventionChristoph B Olivier, Deepak L Bhatt, Sergio Leonardi, et al.Circulation. Cardiovascular Quality and Outcomes|November 12, 2020
Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID TrialAjar Kochar, Hillary Mulder, Frank W Rockhold, et al.American Heart Journal|May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialRaffaele De Caterina, Ulrika Andersson, John H Alexander, et al.Journal of the American College of Cardiology|August 14, 2015
Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 TrialConnie N Hess, Stefan James, Renato D Lopes, et al.Journal of the American College of Cardiology|March 18, 2026
Comparative Prognosis of Chagas and Other CardiomyopathiesRyohei Ono, Kieran F Docherty, Alasdair D Henderson, et al.Circulation. Cardiovascular Quality and Outcomes|June 14, 2013
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryMichael W Cullen, Sunghee Kim, Jonathan P Piccini, et al.JAMA|June 6, 2012
Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trialOtávio Berwanger, Hélio P Guimarães, Ligia N Laranjeira, et al.Pageof 112